Raia Drogasil S.A.

BOVESPA:RADL3 Stock Report

Market Cap: R$39.2b

Raia Drogasil Future Growth

Future criteria checks 5/6

Raia Drogasil is forecast to grow earnings and revenue by 20.1% and 12.5% per annum respectively. EPS is expected to grow by 17.6% per annum. Return on equity is forecast to be 22.7% in 3 years.

Key information

20.1%

Earnings growth rate

17.56%

EPS growth rate

Consumer Retailing earnings growth21.3%
Revenue growth rate12.5%
Future return on equity22.68%
Analyst coverage

Good

Last updated19 Nov 2025

Recent future growth updates

Results: Raia Drogasil S.A. Beat Earnings Expectations And Analysts Now Have New Forecasts

Aug 08
Results: Raia Drogasil S.A. Beat Earnings Expectations And Analysts Now Have New Forecasts

Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models

May 09
Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Raia Drogasil S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Mar 01
Raia Drogasil S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Recent updates

The Return Trends At Raia Drogasil (BVMF:RADL3) Look Promising

Sep 14
The Return Trends At Raia Drogasil (BVMF:RADL3) Look Promising

Here's Why Raia Drogasil (BVMF:RADL3) Can Manage Its Debt Responsibly

Aug 27
Here's Why Raia Drogasil (BVMF:RADL3) Can Manage Its Debt Responsibly

Earnings Not Telling The Story For Raia Drogasil S.A. (BVMF:RADL3) After Shares Rise 27%

Aug 09
Earnings Not Telling The Story For Raia Drogasil S.A. (BVMF:RADL3) After Shares Rise 27%

Results: Raia Drogasil S.A. Beat Earnings Expectations And Analysts Now Have New Forecasts

Aug 08
Results: Raia Drogasil S.A. Beat Earnings Expectations And Analysts Now Have New Forecasts

Raia Drogasil (BVMF:RADL3) Might Have The Makings Of A Multi-Bagger

Jun 16
Raia Drogasil (BVMF:RADL3) Might Have The Makings Of A Multi-Bagger

Raia Drogasil S.A.'s (BVMF:RADL3) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

May 11
Raia Drogasil S.A.'s (BVMF:RADL3) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models

May 09
Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Is Raia Drogasil (BVMF:RADL3) Using Too Much Debt?

Apr 29
Is Raia Drogasil (BVMF:RADL3) Using Too Much Debt?

Raia Drogasil S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Mar 01
Raia Drogasil S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Raia Drogasil (BVMF:RADL3) Is Experiencing Growth In Returns On Capital

Feb 24
Raia Drogasil (BVMF:RADL3) Is Experiencing Growth In Returns On Capital

These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well

Jan 19
These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well
User avatar

RD Saude's Expansion And Digital Investment Ignite Growth In The Health Market

Expansion and digital investment aim to increase market share and boost revenue via mature store growth and new store openings.

Raia Drogasil S.A.'s (BVMF:RADL3) Price In Tune With Earnings

Nov 26
Raia Drogasil S.A.'s (BVMF:RADL3) Price In Tune With Earnings

Earnings and Revenue Growth Forecasts

BOVESPA:RADL3 - Analysts future estimates and past financials data (BRL Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202756,3172,0211,0423,26610
12/31/202650,0421,6047982,70711
12/31/202543,6911,2865672,39910
9/30/202542,2351,3401,7083,111N/A
6/30/202540,9591,2211,4992,893N/A
3/31/202539,8151,1741,2992,650N/A
12/31/202438,8641,1981,5002,784N/A
9/30/202437,7011,1101,1092,360N/A
6/30/202436,3881,0394411,671N/A
3/31/202435,1431,0517652,032N/A
12/31/202333,9741,0554811,785N/A
9/30/202332,8861,0797142,034N/A
6/30/202331,7001,0318832,186N/A
3/31/202330,4361,0481,0072,248N/A
12/31/202229,0679964931,682N/A
9/30/202227,7058815631,590N/A
6/30/202226,3808208711,805N/A
3/31/202225,0697183221,232N/A
12/31/202124,1277527011,557N/A
9/30/202123,2077437721,577N/A
6/30/202122,1367439841,737N/A
3/31/202120,7375357161,349N/A
12/31/202020,0674848011,477N/A
9/30/202019,298409620901N/A
6/30/202018,80671373311N/A
3/31/202018,562807680969N/A
12/31/201917,566772462749N/A
9/30/201916,778803103805N/A
6/30/201915,933472N/A985N/A
3/31/201915,321470N/A708N/A
12/31/201814,801502N/A683N/A
9/30/201814,306519N/A570N/A
6/30/201813,966527N/A674N/A
3/31/201813,589528N/A691N/A
12/31/201713,213511N/A629N/A
9/30/201712,768464N/A601N/A
6/30/201712,252444N/A603N/A
3/31/201711,798462N/A597N/A
12/31/201611,257448N/A556N/A
9/30/201610,658438N/A528N/A
6/30/201610,042407N/A390N/A
3/31/20169,446360N/A410N/A
12/31/20158,898340N/A502N/A
9/30/20158,448325N/A505N/A
6/30/20158,074309N/A432N/A
3/31/20157,668263N/A437N/A
12/31/20147,351221N/A340N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: RADL3's forecast earnings growth (20.1% per year) is above the savings rate (11.8%).

Earnings vs Market: RADL3's earnings (20.1% per year) are forecast to grow faster than the BR market (13.1% per year).

High Growth Earnings: RADL3's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: RADL3's revenue (12.5% per year) is forecast to grow faster than the BR market (6.5% per year).

High Growth Revenue: RADL3's revenue (12.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: RADL3's Return on Equity is forecast to be high in 3 years time (22.7%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/24 05:34
End of Day Share Price 2025/11/24 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Raia Drogasil S.A. is covered by 24 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andréa AznarBB Banco de Investimento S.A.
Robert Ford AguilarBofA Global Research
Frederico MendesBradesco S.A. Corretora de Títulos e Valores Mobiliários